Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (181) 181
life sciences & biomedicine (180) 180
cardiovascular system & cardiology (159) 159
cardiac & cardiovascular systems (158) 158
humans (127) 127
male (83) 83
female (77) 77
aged (65) 65
middle aged (58) 58
abridged index medicus (55) 55
treatment outcome (51) 51
stents (50) 50
cardiovascular (49) 49
percutaneous coronary intervention (43) 43
biological and medical sciences (42) 42
medical sciences (41) 41
mortality (39) 39
myocardial infarction (39) 39
cardiology and cardiovascular medicine (37) 37
heart attacks (36) 36
internal medicine (35) 35
risk factors (35) 35
acute coronary syndromes (32) 32
clinical trials (32) 32
aspirin (31) 31
coronary heart disease (31) 31
cardiology (30) 30
drug-eluting stents (30) 30
cardiology. vascular system (28) 28
care and treatment (27) 27
heart (27) 27
cardiovascular disease (26) 26
coronary vessels (25) 25
risk assessment (25) 25
bleeding (24) 24
thrombosis (24) 24
patients (23) 23
stroke (23) 23
prospective studies (22) 22
stent (21) 21
angioplasty (20) 20
cardiac patients (20) 20
time factors (20) 20
clopidogrel (19) 19
drug therapy, combination (19) 19
myocardial infarction - etiology (19) 19
platelet aggregation inhibitors - therapeutic use (19) 19
coronary artery disease (17) 17
coronary artery disease - therapy (17) 17
percutaneous coronary intervention - methods (17) 17
platelet aggregation inhibitors - administration & dosage (17) 17
aged, 80 and over (16) 16
coronary angiography (16) 16
dual antiplatelet therapy (16) 16
clinical outcomes (15) 15
general & internal medicine (15) 15
peripheral vascular disease (15) 15
prognosis (15) 15
radiotherapy. instrumental treatment. physiotherapy. reeducation. rehabilitation, orthophony, crenotherapy. diet therapy and various other treatments (15) 15
surgery. transplantations, organ and tissue grafts. graft diseases (15) 15
anticoagulants (14) 14
drug therapy (14) 14
drug-eluting stent (14) 14
medicin och hälsovetenskap (14) 14
medicine, general & internal (14) 14
myocardial infarction - mortality (14) 14
myocardial infarction - therapy (14) 14
ticagrelor (14) 14
analysis (13) 13
ischemia (13) 13
ticlopidine - analogs & derivatives (13) 13
acute coronary syndrome (12) 12
angioplasty, balloon, coronary - adverse effects (12) 12
cardiovascular diseases (12) 12
coronary artery disease - surgery (12) 12
follow-up studies (12) 12
implants (12) 12
myocardial infarction - prevention & control (12) 12
percutaneous coronary intervention - adverse effects (12) 12
platelet aggregation inhibitors - adverse effects (12) 12
sirolimus - analogs & derivatives (12) 12
surgery (12) 12
aspirin - therapeutic use (11) 11
coronary artery disease - mortality (11) 11
heart attack (11) 11
human medicine (11) 11
medical and health sciences (11) 11
percutaneous coronary intervention - mortality (11) 11
research (11) 11
stroke - etiology (11) 11
stroke - prevention & control (11) 11
thromboembolism (11) 11
aspirin - administration & dosage (10) 10
cerebral infarction (10) 10
clinical medicine (10) 10
clinical trials as topic (10) 10
consortia (10) 10
diabetes (10) 10
kaplan-meier estimate (10) 10
medical imaging (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial
by Silber, Sigmund, Prof and Windecker, Stephan, Prof and Vranckx, Pascal, MD and Serruys, Patrick W, Prof and on behalf of the RESOLUTE All Comers investigators and RESOLUTE All Corners Investigators and RESOLUTE All Comers investigators
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 377, Issue 9773, pp. 1241 - 1247
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) | Prospective Studies | Follow-Up Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Death, Sudden, Cardiac - prevention & control | Male | Secondary Prevention - methods | Adult | Female | Myocardial Revascularization - statistics & numerical data | Everolimus | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Europe | Coronary Restenosis - prevention & control | Treatment Outcome | Coronary Restenosis - diagnostic imaging | Coronary Angiography | Confounding Factors (Epidemiology) | Coronary Artery Disease - therapy | Aged | Myocardial Infarction - prevention & control | Israel | Complications and side effects | Usage | Dosage and administration | Cardiovascular diseases | Drug therapy | Health aspects | Stent (Surgery) | Cardiovascular agents | Heart attacks | Cardiovascular disease | Circulatory system | Clinical medicine | Acute coronary syndromes | Stents | Blood clots | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial
by Valgimigli, Marco, Dr and Gagnor, Andrea, MD and Calabró, Paolo, MD and Frigoli, Enrico, MD and Leonardi, Sergio, MD and Zaro, Tiziana, MD and Rubartelli, Paolo, MD and Briguori, Carlo, MD and Andò, Giuseppe, MD and Repetto, Alessandra, MD and Limbruno, Ugo, MD and Cortese, Bernardo, MD and Sganzerla, Paolo, MD and Lupi, Alessandro, MD and Galli, Mario, MD and Colangelo, Salvatore, MD and Ierna, Salvatore, MD and Ausiello, Arturo, MD and Presbitero, Patrizia, MD and Sardella, Gennaro, Prof and Varbella, Ferdinando, MD and Esposito, Giovanni, MD and Santarelli, Andrea, MD and Tresoldi, Simone, MD and Nazzaro, Marco, MD and Zingarelli, Antonio, MD and de Cesare, Nicoletta, MD and Rigattieri, Stefano, MD and Tosi, Paolo, MD and Palmieri, Cataldo, MD and Brugaletta, Salvatore, MD and Rao, Sunil V, MD and Heg, Dik, PhD and Rothenbühler, Martina, MSc and Vranckx, Pascal, MD and Jüni, Peter, Prof and MATRIX Investigators
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 385, Issue 9986, pp. 2465 - 2476
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Catheterization, Peripheral - methods | Blood Loss, Surgical - prevention & control | Humans | Acute Coronary Syndrome - mortality | Male | Survival Rate | Treatment Outcome | Cause of Death | Coronary Angiography | Radial Artery | Percutaneous Coronary Intervention - methods | Acute Coronary Syndrome - surgery | Female | Femoral Artery | Aged | Blood Loss, Surgical - mortality | Catheterization, Peripheral - adverse effects | Clinical trials | Care and treatment | Coronary heart disease | Cardiac patients | Heart attacks | Acute coronary syndromes | Cardiology | Mortality | Veins & arteries | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
by Vranckx, Pascal and Valgimigli, Marco and Jüni, Peter and Hamm, Christian and Steg, Philippe Gabriel and Heg, Dik and van Es, Gerrit Anne and McFadden, Eugene P and Onuma, Yoshinobu and van Meijeren, Cokky and Chichareon, Ply and Benit, Edouard and Möllmann, Helge and Janssens, Luc and Ferrario, Maurizio and Moschovitis, Aris and Zurakowski, Aleksander and Dominici, Marcello and Van Geuns, Robert Jan and Huber, Kurt and Slagboom, Ton and Serruys, Patrick W and Windecker, Stephan and Abdellaoui, Mohamed and Adlam, David and Akin, Ibrahim and Albarran Gonzalez-Trevilla, Agustin and Almeida, Manuel and Alves Lemos Neto, Pedro and Aminian, Adel and Anderson, Richard and Andreae, Rick and Angioi, Michael and Asano, Taku and Barbato, Emanuele and Barlis, Peter and Barraud, Pascal and Benit, Edouard and Bertrand, Olivier and Beygui, Farzin and Bolognese, Leonardo and Botelho, Roberto and Bouwman, Coby and Bressers, Marco and Brunel, Philippe and Buszman, Pawel and Buysschaert, Ian and Canas da Silva, Pedro and Carrie, Didier and Cequier, Angel and Chichareon, Ply and Chin Chang, Chun and Chowdhary, Saqib and Collet, Carlos and Colombo, Antonio and Cotton, James and Cruz Ferreira, Rui and Curello, Salvatore and Curzen, Nick and de Bot, Judith and de Vreede, Tone and Delle Karth, Georg and Dijksma, Lynn and Dominici, Marcello and Édes, István and Eeckhout, Eric and Eitel, Ingo and Faluközy, József and Fath-Ordoubadi, Farzin and Ferrario, Maurizio and Fontos, Geza and Francisco Diaz, Jose and Freitas Quintella, Edgard and Frey, Bernhard and Friedrich, Guy and Galasko, Gavin and Galuszka, Grzegorz and Gama Ribeiro, Vasco and Garg, Scot and Gargiulo, Giuseppe and Geisler, Tobias and Gelev, Valeri and Ghandilyan, Art and Goicolea, Javier and Gori, Tommaso and Gragnano, Felice and Guimarães, Ana and Hamm, Christian and Haude, Michael and Heg, Dik and Heijke, Pieter and Hernández Antolin, Rosa Ana and Hildick-Smith, David and Hillen, Dorien and Hoekman, Ina and Hofma, Sjoerd and Holmvang, Lene and Hoole, Stephen and Horváth, Iván and Huber, Kurt and ... and GLOBAL LEADERS Investigators
The Lancet (British edition), ISSN 0140-6736, 09/2018, Volume 392, Issue 10151, pp. 940 - 949
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Myocardial Infarction - mortality | Purinergic P2Y Receptor Antagonists - administration & dosage | Humans | Middle Aged | Male | Coronary Artery Disease - drug therapy | Coronary Artery Disease - mortality | Adenosine - administration & dosage | Ticlopidine - analogs & derivatives | Aspirin - administration & dosage | Drug-Eluting Stents - adverse effects | Coronary Angiography | Adenosine - analogs & derivatives | Platelet Aggregation Inhibitors - administration & dosage | Intention to Treat Analysis | Ticlopidine - administration & dosage | Clopidogrel | Female | Aged | Myocardial Infarction - prevention & control | Drug Therapy, Combination | Ticagrelor | Percutaneous Coronary Intervention | Aggregation | Blood platelets | Analysis | Myocardial infarction | Intervention | Therapy | Surgical implants | Heart attacks | Disorders | Cardiovascular disease | Drug delivery | Evidence-based medicine | Bleeding | Subgroups | Consortia | Randomization | Motivation | Implants | Heart diseases | Stents | Drug dosages | Aspirin | Stroke | Mortality | Coronary artery | Implantation | Coronary artery disease | Patients | Coronary vessels | Fatalities | Infarction | Acute coronary syndromes | Biosensors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Zotarolimus-Eluting Versus Bare-Metal Stents in Uncertain Drug-Eluting Stent Candidates
by Valgimigli, Marco, MD, PhD and Patialiakas, Athanasios, MD and Thury, Attila, MD, PhD and McFadden, Eugene, MD and Colangelo, Salvatore, MD and Campo, Gianluca, MD and Tebaldi, Matteo, MD and Ungi, Imre, MD, PhD and Tondi, Stefano, MD and Roffi, Marco, MD and Menozzi, Alberto, MD, PhD and de Cesare, Nicoletta, MD and Garbo, Roberto, MD and Meliga, Emanuele, MD and Testa, Luca, MD, PhD and Gabriel, Henrique Mesquita, MD and Airoldi, Flavio, MD and Ferlini, Marco, MD and Liistro, Francesco, MD and Dellavalle, Antonio, MD and Vranckx, Pascal, MD, PhD and Briguori, Carlo, MD, PhD and ZEUS Investigators
Journal of the American College of Cardiology, ISSN 0735-1097, 2015, Volume 65, Issue 8, pp. 805 - 815
Cardiovascular | Internal Medicine | dual-antiplatelet therapy | high bleeding risk | high thrombotic risk | zotarolimus-eluting stent(s) | drug-eluting stent(s) | dualantiplatelet therapy | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Coronary Artery Disease - surgery | Humans | Immunosuppressive Agents - therapeutic use | Postoperative Complications - prevention & control | Male | Hemorrhage - prevention & control | Aspirin - administration & dosage | Drug-Eluting Stents - adverse effects | Coronary Restenosis - diagnosis | Coronary Angiography - methods | Aspirin - adverse effects | Percutaneous Coronary Intervention - methods | Hemorrhage - etiology | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Aged, 80 and over | Ticlopidine - administration & dosage | Female | Coronary Restenosis - etiology | Platelet Aggregation Inhibitors - adverse effects | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Risk Assessment | Risk Factors | Coronary Restenosis - prevention & control | Treatment Outcome | Postoperative Complications - diagnosis | Ticlopidine - analogs & derivatives | Coronary Artery Disease - diagnosis | Aged | Biocompatible Materials - therapeutic use | Percutaneous Coronary Intervention - adverse effects | Sects | Stent (Surgery) | Heart attacks | Drug therapy | Stents | Coronary vessels | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text 4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New-Generation Drug-Eluting Stents
by Taniwaki, Masanori, MD and Stefanini, Giulio G., MD and Silber, Sigmund, MD, PhD and Richardt, Gert, MD and Vranckx, Pascal, MD and Serruys, Patrick W., MD, PhD and Buszman, Pawel E., MD and Kelbaek, Henning, MD and Windecker, Stephan, MD and RESOLUTE All-Comers Investigators
Journal of the American College of Cardiology, ISSN 0735-1097, 2014, Volume 63, Issue 16, pp. 1617 - 1625
Cardiovascular | Internal Medicine | everolimus-eluting stent(s) | all-comers population | long-term outcomes | Resolute zotarolimus-eluting stent(s) | drug-eluting stent(s) | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Sects | Medical colleges | Angiogenesis inhibitors | Stent (Surgery) | Heart attacks | Cardiology | Stents | Coronary vessels | Clinical outcomes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial
by Vranckx, Pascal and Valgimigli, Marco and Eckardt, Lars and Tijssen, Jan and Lewalter, Thorsten and Gargiulo, Giuseppe and Batushkin, Valerii and Campo, Gianluca and Lysak, Zoreslava and Vakaliuk, Igor and Milewski, Krzysztof and Laeis, Petra and Reimitz, Paul-Egbert and Smolnik, Rüdiger and Zierhut, Wolfgang and Goette, Andreas
The Lancet (British edition), ISSN 0140-6736, 10/2019, Volume 394, Issue 10206, pp. 1335 - 1343
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Stroke - prevention & control | Atrial Fibrillation - drug therapy | Humans | Middle Aged | Atrial Fibrillation - complications | Male | Thiazoles - therapeutic use | Factor Xa Inhibitors - therapeutic use | Stroke - etiology | Vitamin K - antagonists & inhibitors | Acute Coronary Syndrome - complications | Fibrinolytic Agents - therapeutic use | Acute Coronary Syndrome - surgery | Female | Aged | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Stents | Percutaneous Coronary Intervention | Purinergic P2Y Receptor Antagonists - therapeutic use | Pyridines - therapeutic use | Care and treatment | Atrial fibrillation | Analysis | Cardiac patients | Intervention | Cardiac arrhythmia | Heart attacks | Cardiovascular disease | Family medical history | Dosage | Bleeding | Randomization | Fibrillation | Electrocardiography | Safety | P-Glycoprotein | Heart diseases | Vitamin K | Creatinine | Anticoagulants | Aspirin | Stroke | Coronary artery | Glycoproteins | Coronary artery disease | Patients | Thrombosis | Inhibitors | Coronary vessels | Phylloquinone | Acute coronary syndromes | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Atrial fibrillation patients undergoing percutaneous coronary intervention: dual or triple antithrombotic therapy with non-vitamin K antagonist oral anticoagulants
by Goette, Andreas and Vranckx, Pascal
European heart journal supplements, ISSN 1520-765X, 09/2020, Volume 22, Issue Supplement_I, pp. I22 - I31
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Standardization of Fractional Flow Reserve Measurements
by Toth, Gabor G., MD and Johnson, Nils P., MD and Jeremias, Allen, MD, MSc and Pellicano, Mariano, MD and Vranckx, Pascal, MD, PhD and Fearon, William F., MD and Barbato, Emanuele, MD, PhD and Kern, Morton J., MD and Pijls, Nico H.J., MD, PhD and De Bruyne, Bernard, MD, PhD
Journal of the American College of Cardiology, ISSN 0735-1097, 2016, Volume 68, Issue 7, pp. 742 - 753
Cardiovascular | Internal Medicine | coronary artery disease | functional assessment | percutaneous coronary intervention | Research Support, Non-U.S. Gov't | Cardiology and Cardiovascular Medicine | Review | Journal Article | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Coronary Artery Disease - surgery | Reference Standards | Coronary Artery Disease - physiopathology | Coronary Artery Disease - diagnosis | Coronary Vessels - physiology | Humans | Blood Flow Velocity - physiology | Fractional Flow Reserve, Myocardial - physiology | Percutaneous Coronary Intervention | Medical colleges | Cardiology | Atherosclerosis | Cardiovascular agents | Heart failure | Automation | Data analysis | Heart attacks | Laboratories | Decision making | Standardization | Clinical trials | Cardiovascular disease | Patients | Clinical outcomes | Catheters | Accuracy | Ischemia | Coronary vessels | Physiology | Acute coronary syndromes | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial
by Camenzind, Edoardo, Dr and Wijns, William, MD and Mauri, Laura, MD and Kurowski, Volkhard, MD and Parikh, Keyur, MD and Gao, Runlin, Prof and Bode, Christoph, Prof and Greenwood, John P, MD and Boersma, Eric, Prof and Vranckx, Pascal, MD and McFadden, Eugene, MD and Serruys, Patrick W, Prof and O'Neil, William W, MD and Jorissen, Brenda, PhD and Van Leeuwen, Frank, MD and Steg, Ph Gabriel, Prof and for the PROTECT Steering Committee and Investigators and PROTECT Steering Comm Investigator and PROTECT Steering Committee and Investigators
The Lancet (British edition), ISSN 0140-6736, 2012, Volume 380, Issue 9851, pp. 1396 - 1405
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antibacterial agents | Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) | Antibiotics. Antiinfectious agents. Antiparasitic agents | Sirolimus - administration & dosage | Sirolimus - analogs & derivatives | Coronary Artery Disease - therapy | Thrombosis - etiology | Humans | Middle Aged | Coronary Artery Disease - pathology | Female | Male | Aged | Coronary Restenosis - etiology | Drug-Eluting Stents - adverse effects | Cell proliferation | Physiological aspects | Research | Drug-eluting stents | Studies | Heart attacks | Acute coronary syndromes | Stents | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights